Advertisement

Hypoglycemic Brain Damage

  • Roland N. Auer
Chapter

Abstract

Before the discovery of insulin, sources of insulin exogenous to the body were not available and hypoglycemic brain damage occurred only in the context of endogenous tumors of the islets of Langerhans of the pancreas (Auer 1986). Human consumption of food had reached the point where diabetes was becoming more common, but it was then only treatable through starvation. Indeed, diabetes can metabolically be considered “starvation in the midst of plenty” due to the inability of glucose to enter cells, in the face of high blood glucose levels. Once insulin was discovered, it was tested in diabetes and was found to allow improved survival over the unpalatable treatment option of starvation: the latter could reduce glucose loss through the urine but only slowed the diabetic process and could not stave off eventual death.

When insulin was discovered in 1921, islet cell adenoma was joined by diabetic insulin treatment in reports of hypoglycemic brain damage (Bodechtel 1933; Baker 1938). Suicide or homicide with insulin also occurred regularly, and together with medication error, provided a steady source of material with hypoglycemic brain damage. Tumors secreting insulin or congener molecules were later recognized to cause hypoglycemia (Le Roith 1999).

Keywords

Krebs Cycle High Blood Glucose Level Neuronal Necrosis Diabetic Insulin Treatment Cell Membrane Break 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Agardh C-D, Folbergrová J, Siesjö BK (1978) Cerebral metabolic changes in profound insulin-induced hypoglycemia, and in the recovery period following glucose administration. J Neurochem 31:1135–1142PubMedCrossRefGoogle Scholar
  2. Auer RN (1986) Progress review: hypoglycemic brain damage. Stroke 17:699–708PubMedGoogle Scholar
  3. Auer RN, Siesjö BK (1993) Hypoglycaemia: brain neurochemistry and neuropathology. Baillières Clin Endocrinol Metab 7:611–625PubMedCrossRefGoogle Scholar
  4. Auer RN, Olsson Y, Siesjö BK (1984) Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: A quantitative study. Diabetes 33:1090–1098PubMedCrossRefGoogle Scholar
  5. Auer R, Kalimo H, Olsson Y, Wieloch T (1985) The dentate gyrus in hypoglycemia: Pathology implicating excitotoxin-mediated neuronal necrosis. Acta Neuropathol (Berl) 67:279–288CrossRefGoogle Scholar
  6. Baker AB (1938) Cerebral lesions in hypoglycemia. II. Some possibilities of irrevocable damage from insulin shock. Arch Pathol 26:765–776Google Scholar
  7. Bodechtel G (1933) Der Hypoglykämische Shock und seine Wirkung auf das Zentralnervensystem. Deutsches Arch f klin Med 175:188–201Google Scholar
  8. Cammermeyer J (1938) Über Gehirnveränderungen, entstanden unter Sakelscher Insulintherapie bei einem Schizophrenen. Z ges Neurol Psychiat 163:617–633CrossRefGoogle Scholar
  9. Cravioto RO, Massieu H, Izquierdo JJ (1951) Free amino acids in rat brain during insulin shock. Proc Soc Exp Biol Med 78:856–858PubMedGoogle Scholar
  10. Döring G (1938) Zur Histopathologie und Pathogenese des tödlichen Insulinshocks. Deutsche Ztschr Nervenheilkunde 147:217–227CrossRefGoogle Scholar
  11. Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 17:1143–1151PubMedCrossRefGoogle Scholar
  12. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R (1995) In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21:1465–1468PubMedGoogle Scholar
  13. Ha HC, Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96:13978–13982PubMedCrossRefGoogle Scholar
  14. Kiessling M, Auer RN, Kleihues P, Siesjö BK (1986) Cerebral protein synthesis during long-term recovery from severe hypoglycemia. J Cereb Blood Flow Metab 6:42–51PubMedCrossRefGoogle Scholar
  15. LaManna JC, Harik SI (1985) Regional comparisons of brain glucose influx. Brain Res 326:299–305PubMedCrossRefGoogle Scholar
  16. Le Roith D (1999) Tumor-induced hypoglycemia. N Engl J Med 341:757–758PubMedCrossRefGoogle Scholar
  17. MacKeith SA, Meyer A (1939) A death during insulin treatment of schizophrenia; with pathological report. J Ment Sci 85:96–105Google Scholar
  18. Mayer-Gross W (1951) Insulin coma therapy of schizophrenia: Some critical remarks on Dr. Sakel’s report. J Ment Sci 97:132–135PubMedGoogle Scholar
  19. Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719–721PubMedCrossRefGoogle Scholar
  20. Olney JW (1971) Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. J Neuropathol Exp Neurol 30:75–90PubMedCrossRefGoogle Scholar
  21. Ouyang YB, He QP, Li PA, Janelidze S, Wang GX, Siesjö BK (2000) Is neuronal injury caused by hypoglycemic coma of the necrotic or apoptotic type? Neurochem Res 25:661–667PubMedCrossRefGoogle Scholar
  22. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: Evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240PubMedCrossRefGoogle Scholar
  23. Pieper AA, Verma A, Zhang J, Snyder SH (1999) Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20:171–181PubMedCrossRefGoogle Scholar
  24. Sakel M (1937) The methodical use of hypoglycemia in the treatment of psychoses. Am J Psychiatry 94:111–129Google Scholar
  25. Sandberg M, Butcher SP, Hagberg H (1986) Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem 47:178–184PubMedCrossRefGoogle Scholar
  26. Suh SW, Aoyama K, Matsumori Y, Liu J, Swanson RA (2005) Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54:1452–1458PubMedCrossRefGoogle Scholar
  27. Suh SW, Aoyama K, Alano CC, Anderson CM, Hamby AM, Swanson RA (2007a) Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1. Mol Med 13:344–349PubMedCrossRefGoogle Scholar
  28. Suh SW, Hamby AM, Swanson RA (2007b) Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 55:1280–1286PubMedCrossRefGoogle Scholar
  29. Sutherland GR, Tyson RL, Auer RN (2008) Truncation of the Krebs cycle during hypoglycemic coma. Med Chem 4:379–385Google Scholar
  30. Trump BF, Goldblatt PJ, Stowell RE (1965) Studies on necrosis of mouse liver in vitro. Ultrastructural alterations in the mitochondria of hepatic parenchymal cells. Lab Invest 14:343–371PubMedGoogle Scholar
  31. Weil A, Liebert E, Heilbrunn G (1938) Histopathologic changes in the brain in experimental hyperinsulinism. Arch Neurol Psychiatry (Chic) 39:467–481Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineHealth Sciences Centre, University of CalgaryCalgaryCanada

Personalised recommendations